Another study found that GLP-1 agonists are associated with a lower risk of major adverse kidney events and death from cardiovascular causes in people with type 2 diabetes and chronic kidney disease
Glp-1 aldm 1 haftadr kullanyorum faydasndan ok zarar oldu hap kullanmaya baladktan sonra kant yapt ve kilo ...vermeyle itah kapatmayla alakas bile yok elindekileri iade etmek istiyorum 980 TL para harcadm bu rne ben yetkililere duyuruyorum
Here is what the FDA says about it (from 02/06/26): Misleading people about the unverified quality, safety, and efficacy of a compounded drug while claiming this is filling a gap in care, while MIDI is valued at $1 billion because of the ability to turn a big profit, is fucking gross
In nutrient-rich conditions, mTOR remains active, suppressing autophagy initiation, while under stress conditions such as energy deficiency or DNA damage, the activation of AMP-activated protein kinase (AMPK), p53 or inhibition of pathways like PI3K/Akt and ERK reduces mTOR activity, which then releases the inhibition on autophagy and facilitates its initiation (Yang and Klionsky, 2010)
Chi, M.S., C.J